Connecticut v. Connecticut Chiropractic Ass’n et al. (Conn. Super. Ct. Hartford March 25, 2008)
State alleged that members of both trade groups, spurred on by their leadership,
illegally agreed to boycott Anthem Health Plans, Inc.’s intention to form a new network for chiropractic services that would be administered by American Specialty Health Networks, Inc. (ASH). Hirtle (longtime counsel to CCA) facilitated the conspiracy by aggressively urging chiropractors to opt out
of the proposed network. Chiropractors feared that the ASH contract would lower reimbursement rates for chiropractic services. The state alleged that the illegal boycott improperly influenced the rates paid to
chiropractors; raised chiropractic costs for Anthem; and deprived Anthem, ASH
and consumers of the benefits of competition among chiropractors. Under the settlements, the CCA, CCC and Hirtle have agreed to pay civil penalties to the state, as well as adopt several measures to prevent future anticompetitive practices.
State of Colorado et al v. Warner Chilcott, 1:05-cv-02182 (D.D.C.2005)
34 states filed suit alleging that Warner Chilcott entered into an illegal agreement with Barr Pharmaceuticals to raise the prices of Ovcon, an oral contraceptive. The lawsuit alleged that after Barr Pharmaceuticals publicly announced that it planned to have a generic version of Ovcon on the market by the end of the year, Warner Chilcott paid Barr Pharmaceuticals $1 million for an agreement designed to prevent Barr’s generic product from coming to market. Under the terms of the alleged agreement, once Barr received FDA approval to market generic Ovcon, Warner Chilcott had 90 days to pay Barr $19 million, after which Barr would refuse to bring the cheaper generic version to the market. The lawsuit alleged that as a result of the agreement, Warner Chilcott paid Barr a total of $20 million to keep it from marketing its generic version of Ovcon. In additon to a payment of $5.5 million, the settlement prohibits Warner Chilcott, for ten years, from entering into any agreement that would have the effect of limiting the research, development, manufacture, or sale of a generic alternative to one of its drugs. Furthermore, Warner Chilcott must provide the states notice of certain agreements it has entered into with generic manufacturers, and must continue to make its records available to the states for inspection to determine whether the company is complying with the terms of the agreement.
Pennsylvania v. University of Pittsburgh Medical Center (W.D. Pa)
State entered into a consent decree with University of Pittsburgh Medical Center to remedy anticompetitive concerns with acquisition of Mercy Medical Systems in Western Pennsylvania.
Maryland v. Rite-Aid Corp.
Rite Aid sought to acquire the assets of Canadian company Jean Coutu, which owned the Eckerd and Brooks retail pharmacy chains. Parties agreed to divest 26 stores in seven states.
Florida v. Columbia/HCA Healthcare Corporation, Healthtrust, Inc., Memorial Health Systems, Inc. and Halifax Hospital Medical Center
As part of a negotiated settlement, the State of Florida and the Federal Trade Commission (FTC) sought to enjoin the merger of defendant hospital facilities, alleging that such acquisitions would result in a substantial reduction of competition in the marketplace for medical care.
Florida v. Service Corp. International, In re Service Corp. International, FTC File No. 981-353 (1/15/99)
As part of a negotiated consent decree, the State of Florida and the Federal Trade Commission (FTC) sought to enjoin the proposed merger between Services Corp. International (SCI) and Equity Corp. International (ECI), alleging that the merger would substantially impair competition among funeral home or cemetery establishments in 14 local markets.
Florida v. El Paso Energy Corporation And the Coastal Corporation, In re El Paso Energy Corp., FTC File No. 001-0086, 1/29/01
As part of a negotiated consent decree, the State of Florida and the Federal Trade Commission sought to enjoin the proposed merger between El Paso Energy Corp. (El Paso) and Coastal Corp. (Coastal)., alleging that the acquisition of Coastal by El Paso would substantially impair competition and would potentially forestall new competition for the transportation of natural gas in the state.
Maine v. Maine Health Alliance, No. CV-03-135 (Kennebec Super Ct. 2003)
Complaint, parallel to FTC action against same Defendants, charges that PHO engaged in price-fixing and concerted refusals to deal in contracting with managed care payors.
New York v. Brooks Drug, Inc, et al., 90 Civ. 4330 (S.D.N.Y. 1992)
Various pharmacy firms engaged in collusion regarding New York State’s prescription program for state employees.
California v. Valero Energy Corp., No. 01-10895 (C.D. Cal. Dec. 18, 2001)
States sought to enjoin the proposed merger between Valero Energy Corporation (Valero) and Ultramar Diamond Shamrock Corporation (Ultramar), arguing that the merger would substantially lessen competition in the bulk supply and wholesale marketing of gasoline.

